BCM
BlueCrest Capital Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-87,036
| Closed | -$2.42M | – | 148 |
|
|
2024
Q1 | $2.42M | Sell |
87,036
-433,861
| -83% | -$12M | 0.12% | 34 |
|
|
2023
Q4 | $15M | Buy |
520,897
+442,039
| +561% | +$12.7M | 0.57% | 9 |
|
|
2023
Q3 | $2.62M | Buy |
78,858
+61,909
| +365% | +$2.05M | 0.12% | 47 |
|
|
2023
Q2 | $622K | Buy |
+16,949
| New | +$622K | 0.02% | 97 |
|
|
2019
Q4 | – | Sell |
-19,956
| Closed | -$717K | – | 527 |
|
|
2019
Q3 | $717K | Buy |
19,956
+12,991
| +187% | +$467K | 0.05% | 217 |
|
|
2019
Q2 | $302K | Sell |
6,965
-265,353
| -97% | -$11.5M | 0.02% | 272 |
|
|
2019
Q1 | $11.6M | Buy |
272,318
+127,261
| +88% | +$5.4M | 0.46% | 24 |
|
|
2018
Q4 | $6.33M | Buy |
+145,057
| New | +$6.33M | 0.33% | 51 |
|
|
2018
Q3 | – | Sell |
-435,609
| Closed | -$15.8M | – | 1702 |
|
|
2018
Q2 | $15.8M | Buy |
+435,609
| New | +$15.8M | 0.41% | 22 |
|
|
2018
Q1 | – | Sell |
-7,007
| Closed | -$254K | – | 1577 |
|
|
2017
Q4 | $254K | Buy |
+7,007
| New | +$254K | 0.01% | 651 |
|
|
2017
Q3 | – | Sell |
-38,042
| Closed | -$1.28M | – | 1007 |
|
|
2017
Q2 | $1.28M | Sell |
38,042
-126,161
| -77% | -$4.24M | 0.05% | 404 |
|
|
2017
Q1 | $5.62M | Buy |
164,203
+84,191
| +105% | +$2.88M | 0.27% | 110 |
|
|
2016
Q4 | $2.6M | Buy |
80,012
+68,718
| +608% | +$2.23M | 0.14% | 198 |
|
|
2016
Q3 | $383K | Buy |
+11,294
| New | +$383K | 0.01% | 546 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 603 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 440 |
|